No Data
No Data
Earnings Preview: EW to Report Financial Results Post-market on April 23
Is Edwards Lifesciences Gaining or Losing Market Support?
Leerink Partners Maintains Edwards Lifesciences(EW.US) With Hold Rating, Announces Target Price $77
Tariff clouds loom heavy! Barclays names the U.S. stock medical instruments Industry as the 'pressure-resistant king' and the 'hard-hit area'.
Barclays issued a research report analyzing the impact of the new tariff policy of the Trump administration on the medical instruments industry.
Barclays Names Most and Least Affected Healthcare Companies From Tariffs
Press Release: Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025